Because no Kaposi cell line was commercially available, we looked for VEGFR-3–positive tumor cell lines using flow cytometry and found that 45% of NCI-H1703 cells expressed VEGFR-3, rendering this cell line a suitable model (Fig. 3A). Here, FLT4 is linked to neoplasm.